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Background: Owing to problems in accurate species identification of the diverse genus clostridium, the
epidemiology and pathogenicity of many species are not fully understood. Moreover, previous studies on
clostridium bacteraemia have been limited and relied only on phenotypic species identification.
Aims: To characterise the epidemiology, disease spectrum, and outcome of clostridium bacteraemia using
16S ribosomal RNA (rRNA) gene sequencing.
Method: During a four year period (1998–2001), all cases of clostridium bacteraemia were prospectively
studied and all ‘‘non-perfringens’’ clostridium isolates identified to the species level by 16S rRNA gene
sequencing.
Results: Fifty one blood culture isolates were identified as Clostridium perfringens and 17 belonged to 11
other clostridium species. The first case of C disporicum infection and two cases of clostridium bacteraemia
in children with intussusception were also described. Of the 68 clostridium isolates from 68 different
patients, 38 were associated with clinically relevant bacteraemia. The gastrointestinal and hepatobiliary
tracts were common sites of both underlying disease and portal of entry in these patients. Clostridium
perfringens accounted for 79% of all clinically relevant bacteraemia, with the remainder caused by a
diversity of species. The attributable mortality rate of clinically relevant clostridium bacteraemia was 29%.
Younger age and underlying gastrointestinal/hepatobiliary tract disease were associated with mortality
(p , 0.05).
Conclusions: Patients with clinically relevant clostridium bacteraemia should be investigated for the
presence of underlying disease processes in the gastrointestinal or hepatobiliary tracts. 16S rRNA gene
analysis will continue to be useful in further understanding the pathogenicity of various clostridium species.
C
lostridium is a heterogeneous genus that consists of
over 150 species. In addition to Clostridium perfringens,
C difficile, C tetani, C botulinum, and C septicum, of which
the epidemiology and clinical disease spectra are well
defined, studies of the pathogenic potential and disease
association of the other clostridium species have been
hampered by difficulties in accurately identifying these
bacteria. For genus identification, spore formation, which is
the most distinguishing feature for differentiating clostri-
dium from other genera of anaerobic Gram positive bacilli, is
sometimes not obvious in bacterial isolates recovered directly
from clinical specimens. For genus and species identification
by commercial kits or analysis of cell wall peptidoglyans and
metabolic end products by gas chromatography mass spectro-
metry, the difficulties lie mainly in the limited database
compared with the large number of clostridium species and a
lack of special equipment and expertise.
‘‘We have used 16S rRNA gene sequencing to define the
epidemiology, clinical disease spectrum, and outcome of
patients with clostridium bacteraemia during a four year
period’’
Comparison of the gene sequences of bacterial species has
shown that the 16S ribosomal RNA (rRNA) gene is highly
conserved within a species and among species of the same
genus. Thus, it can be used as the new standard for classi-
fication and identification of bacteria.1–3 Although clostri-
dium species are common blood culture isolates, no studies
have systematically characterised clostridium bacteraemia by
this genotypic identification method. In our study, we have
used 16S rRNA gene sequencing to define the epidemiology,
clinical disease spectrum, and outcome of patients with
clostridium bacteraemia during a four year period.
MATERIALS AND METHODS
Patients and microbiological methods
The bacterial strains used in our study were isolates from
blood cultures of patients hospitalised at the Queen Mary
Hospital in Hong Kong, China, during a four year period
(January 1998 to December 2001). Clinical data were col-
lected prospectively. Clinical specimens were collected and
handled according to standard protocols.4 The BACTEC 9240
blood culture system (Becton Dickinson, Baltimore,
Maryland, USA) was used. All anaerobic Gram positive
bacilli isolated from blood cultures were identified to the
species level. Isolates were identified as C perfringens by the
presence of double zone haemolysis on blood agar, the ability
to produce lecithinase on egg yolk glucose agar, and the Vitek
System (ANI; bioMerieux Vitek, Hazlewood, Missouri, USA).
Isolates of Propionebacterium acnes were identified by their
ability to produce catalase and indole and the Vitek System
(ANI). All isolates other than C perfringens and P acnes were
subjected to 16S rRNA gene sequencing. All isolates finally
identified as clostridium species were included in our study.
Each isolate was categorised as clinically relevant or a
contaminant (pseudobacteraemia) by clinical and laboratory
criteria, as described previously.5 The criteria include the
patient’s clinical presentation, physical examination findings,
body temperature at the time of the blood culture, leucocyte
and differential cell counts, imaging or operative results,
histopathological findings, number of positive blood cul-
tures out of the total number performed, and response to
Abbreviations: PCR, polymerase chain reaction; rRNA, ribosomal RNA
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treatment. The same isolate recovered from the same patient
was counted only once.
Extraction of bacterial DNA for 16S rRNA gene
sequencing
Briefly, 80 ml of NaOH (0.05M) was added to 20 ml of bacterial
cells suspended in distilled water and the mixture was
incubated at 60˚ C for 45 minutes, followed by the addition of
6 ml of Tris/HCl (pH 7.0), achieving a final pH of 8.0. The
resultant mixture was diluted 6100 and 5 ml of the diluted
extract was used for the polymerase chain reaction (PCR).
PCR, gel electrophoresis, and 16S rRNA gene
sequencing
Briefly, DNase I treated distilled water and PCR master mix
(which contains dNTPs, PCR buffer, and Taq polymerase)
were used in all PCR reactions by adding 1 U of DNase I
(Pharmacia, Uppsala, Sweden) to 40 ml of distilled water or
PCR master mix, incubating the mixture at 25 C˚ for 15
minutes, and subsequently at 95 C˚ for 10 minutes to
inactivate the DNase I. The bacterial DNA extracts and
control were amplified with 0.5mM primers (LPW58, 59-
AGGCCCGGGAACGTATTCAC-39 and LPW81, 59-TGGCG
AACGGGTGAGTAA-39; Gibco BRL, Rockville, Maryland,
USA). The PCR mixture (50 ml) contained bacterial DNA,
PCR buffer (10mM Tris/HCl (pH 8.3), 50mM KCl, 2mM
MgCl2, and 0.01% gelatin), 200 mM of each dNTP, and 1.0 U
Taq polymerase (Boehringer Mannheim, Mannheim,
Germany). The mixtures were amplified by 40 cycles of
94 C˚ for one minute, 55 C˚ for one minute, and 72 C˚ for two
minutes, with a final extension at 72 C˚ for 10 minutes in an
automated 0.5 ml GeneAmp PCR system 9700 (Applied
Biosystems, Foster City, California, USA). DNase I treated
distilled water was used as the negative control. A 10 ml
aliquot of each amplified product was electrophoresed in
1.0% (wt/vol) agarose gel, with a molecular size marker
(l DNA AvaII digest; Boehringer Mannheim) in parallel.
Electrophoresis in Tris/borate/EDTA buffer was performed at
100 V for 1.5 hours. The gel was stained with ethidium
bromide (0.5 mg/ml) for 15 minutes, rinsed, and photo-
graphed under ultraviolet light illumination.
The PCR products were gel purified using the QIAquick
PCR purification kit (Qiagen, Hilden, Germany). Both strands
of the PCR products were sequenced twice with an ABI 377
automated sequencer according to the manufacturers’
instructions (Perkin-Elmer, Foster City, California, USA)
using the PCR primers (LPW58 and LPW81). The sequences
of the PCR products were compared with known 16S rRNA
gene sequences in the GenBank (http://www.ncbi.nlm.nih.
gov) by multiple sequence alignment using the Clustal W
program.6
Statistical analysis
A comparison of characteristics was made between (1)
patients with C perfringens and those with non-perfringens
clostridium bacteraemia, (2) patients who succumbed and
those who survived the clostridium bacteraemia, and (3)
patients with clinically relevant clostridium bacteraemia and
those with pseudobacteraemia. The x2 test was used for
categorical variables and the Student’s t test for age. A p value
, 0.05 was regarded as significant.
RESULTS
Identification of clostridium blood culture isolates
In total, 165 anaerobic Gram positive bacilli were isolated
from the blood cultures during the four year study period. Of
the 165 isolates, 51 were identified as C perfringens and 75 as
P acnes by phenotypic tests. The remaining 39 isolates were
subjected to 16S rRNA gene sequencing. PCR of the 16S
rRNA genes of these isolates showed bands at about 1200 bp.
Sequencing of the 16S rRNA genes revealed that 17 had 16S
rRNA genes with . 97% nucleotide identity to that of known
non-perfringens clostridium species, indicating that they
were non-perfringens clostridium species (table 1). The
remaining 22 isolates were identified as non-spore forming
anaerobic Gram positive bacilli, and these isolates will not be
discussed in the present report. The 68 blood culture isolates
of clostridium (51 of C perfringens and 17 of non-perfringens
clostridium species) were recovered from 68 different
patients. Of these 68 isolates, 38 were associated with
clinically relevant bacteraemia, whereas the remaining 30
were associated with pseudobacteraemia as a result of
contamination. Thirty of the 38 cases of clinically relevant
bacteraemia were caused by C perfringens, three by C ramosum
and one by each of C disporicum, C paraputrificum, C septicum,
C tertium, and C difficile (table 2).
Patient characteristics
Tables 2 and 3 tabulate and summarise the characteristics of
the 38 patients with clinically relevant clostridium bacter-
aemia. The incidence of clostridium bacteraemia was similar
throughout the four year study period and there was no
obvious seasonal variation. The median age was 74 years
(range, 1 month to 95 years). Twenty six patients were over
60. The male to female ratio was 23 : 15. Only four patients
did not have underlying diseases. The major underlying
diseases were gastrointestinal tract disease (11), hepatobili-
ary tract disease (11), malignancy (11), hypertension (11),
diabetes mellitus (seven), cerebrovascular accident (six),
immobilisation and/or bed sore (four), and chronic renal
failure (three). No definite source of the bacteraemia was
identified (primary bacteraemia) in 13 patients, whereas 12
had acute cholecystitis or cholangitis, seven had other intra-
abdominal infections, three had infected gangrene of the
extremities, two had infected bed sores, and one had
pneumonia. Thirty and nine had community and hospital
acquired clostridium bacteraemia, respectively. Thirty four
patients had clostridium recovered from one blood culture,
whereas in four it was recovered from two blood cultures.
Nineteen patients had clostridium as the only bacter-
ium recovered from their blood cultures, whereas in the
other 19, other bacteria were recovered at the same time as
Table 1 Identification of the 17 blood culture isolates of
non-perfringens clostridium by 16S ribosomal RNA
(rRNA) gene sequencing
Isolate
Species identification
by 16S rRNA gene
sequencing
GB AC of
closest match
% Nucleotide
identity*
1 C barati X68174 99.8
2 C difficile AF072474 99.9
3 C disporicum Y18176 99.0
4 C indolis AF028351 97.9
5 C innocuum AF028352 99.9
6 C orbiscindens Y18187 100
7 C paraputrificum AB032556 99.4
8 C paraputrificum AB032556 100
9 C paraputrificum AB032556 100
10 C paraputrificum AB032556 99.8
11 C ramosum M23731 99.8
12 C ramosum M23731 99.9
13 C ramosum M23731 99.8
14 C septicum U59278 99.9
15 C sporosphaeroides M59116 98.5
16 C tertium AF227826 99.9
17 C tertium Y18174 100
AC, accession number; GB, GenBank.
*% Nucleotide identity of 16S rRNA gene sequence to the closest match in
GB.
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Table 2 Characteristics of the 38 patients with clinically relevant clostridium bacteraemia
Patient Sex/Age Underlying disease Diagnosis
Blood culture
isolate
CA/
HA
Positive blood
cultures (n)
Other bacteria
recovered in blood
culture Outcome
1 F/86 Gallstones Infected bed sore C perfringens CA 1 None Cured
2 F/83 Ca cervix with liver
metastasis, gallstones
Primary bacteraemia C perfringens HA 1 None Cured
3 M/59 Liver cirrhosis, hepatic
encephalopathy
Primary bacteraemia C perfringens CA 1 None Died
4 F/44 Carcinoid tumour with liver
metastasis
AC C perfringens CA 1 Klebsiella
pneumoniae
Died
5 M/92 HT, dementia, gallstones AC C perfringens CA 1 Escherichia coli Cured
6 F/77 HT, osteoporosis Primary bacteraemia C perfringens CA 1 None Cured
7 M/1 None Intussusception C perfringens CA 1 E coli, K pneumoniae,
Enterococcus
gallinarum
Died
8 M/26 IVDA Gas gangrene of
right leg
C perfringens CA 2 None Cured
9 F/73 Ca colon, HT, TB Intra-abdominal
abscess
C perfringens CA 1 None Cured
10 M/79 Cholangiocarcinoma,
gallstones
AC C perfringens CA 1 Aeromonas sobria Cured
11 F/88 Dementia, rectovaginal
and vesicovaginal fistula
Infected fistula C perfringens CA 1 None Cured
12 M/78 CVA, SSS, RPC AC C perfringens CA 2 Enterobacter
aerogenes
Cured
13 F/75 Gallstones Acute cholecystitis C perfringens CA 1 E coli Cured
14 M/69 DM, gallstones, fatty liver,
HT, IHD, hyperlipidaemia, PU
Acute cholecystitis C perfringens CA 1 E coli Cured
15 F/69 RA, Ca cervix, irradiation
proctitis, cystitis,
hydronephrosis
Primary bacteraemia C perfringens CA 1 None Cured
16 M/68 HT, PU Acute cholecystitis C perfringens CA 1 E coli Died
17 M/95 Gallstones, CVA AC and acute
cholecystitis
C perfringens CA 1 E coli Cured
18 M/72 DM, HT, PVD, alcoholism Wet gangrene of
?lower limbs
C perfringens CA 1 Streptococcus
dysgalactiae subsp.
dysgalactiae
Cured
19 M/88 Liver cirrhosis, COPD, HT,
DM, CVA, CRF
Primary bacteraemia C perfringens CA 1 None Cured
20 M/84 None AC, subphrenic
abscess
C perfringens CA 1 None Cured
21 F/70 Sjogren’s syndrome,
osteoporosis, PVD, big toe
gangrene, AF
Right foot gangrene C perfringens HA 1 None Died
22 M/72 HT, DM, COPD, CRF, RPC,
old TB, gallstones
AC C perfringens CA 1 E coli, K pneumoniae,
Proteus vulgaris
Died
23 M/64 IHD, DM, HT, colonic
diverticulitum
Acute diverticulitis C perfringens CA 2 E coli, K pneumoniae Cured
24 F/59 RPC AC C perfringens CA 1 E coli Cured
25 M/82 Ca pancreas with peritoneal
carcinomatosis, GIB, IO
Primary bacteraemia C perfringens CA 1 None Cured
26 M/90 None Aspiration pneumonia C perfringens CA 1 None Cured
27 M/46 CRF, liver cirrhosis,
hyperparathyroidism
Spontaneous bacterial
peritonitis
C perfringens CA 1 None Died
28 F/89 IHD, CVA, AF,
bronchiectasis, pyometra
Primary bacteraemia C perfringens CA 1 None Cured
29 M/46 Renal cell Ca with lung and
peritoneal metastasis, GIB
Primary bacteraemia C perfringens HA 1 E coli, K pneumoniae Died
30 F/84 DM, HT, gallstones Acute cholecystitis C perfringens CA 1 E coli, K pneumoniae Cured
31 M/54 HCC, history of liver
abscess, GIB
Primary bacteraemia C ramosum CA 1 Bacteroides fragilis
group
Died
32 M/71 CVA Infected bed sore C ramosum HA 1 Proteus mirabilis Cured
33 M/78 Ca sigmoid with liver
metastasis
Primary bacteraemia C ramosum HA 1 E coli, Pseudomonas
aeruginosa,
Enterococcus avium
Died
34 F/75 Dementia, asthma, HT,
DM, uterine prolapse
Primary bacteraemia C disporicum HA 1 None Cured
35 M/6m None Intussusception with
peritonitis
C paraputrificum CA 1 None Cured
36 F/40 AML, dental caries,
neutropenic fever
Primary bacteraemia C septicum CA 1 None Cured
37 F/12 ALL, mucositis, neutropenic
fever
Primary bacteraemia C tertium HA 2 None Cured
38 M/1m Prematurity Necrotising
enterocolitis
C difficile HA 1 Enterobacter cloacae Died
AC, acute cholangitis; AF, atrial fibrillation; ALL, acute lymphoblastic leukaemia; AML, acute myeloid leukaemia; Ca, carcinoma; CA, community acquired; COPD,
chronic obstructive pulmonary disease; CRF, chronic renal failure; CVA, cerebrovascular accident; DM, diabetes mellitus; F, female; GIB, gastrointestinal bleeding;
HA, hospital acquired; HCC, hepatocellular carcinoma; HT, hypertension; IHD, ischaemic heart disease; IO, intestinal obstruction; IVDA, intravenous drug abuse;
M, male; PU, peptic ulcer; PVD, peripheral vascular disease; RA, rheumatoid arthritis; RPC, recurrent pyogenic cholangitis; SSS, sick sinus syndrome; TB,
tuberculosis.
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clostridium, with Escherichia coli isolated in 12 cases, Klebsiella
pneumoniae in six, Aeromonas sobria, Bacteroides fragilis group,
Enterobacter aerogenes, Enterobacter cloacae, Enterococcus avium,
Enterococcus gallinarum, Proteus mirabilis, Pseudomonas aerugi-
nosa, and Lancefield group G beta-haemolytic Streptococcus
dysgalactiae subspecies dysgalactiae each in one. Overall, 11
patients died.
Table 4 compares and summarises the characteristics of
patients with C perfringens and those with non-perfringens
clostridium bacteraemia. Older age, a diagnosis of cholecys-
titis/cholangitis, and community acquired infections were
associated with C perfringens bacteraemia (p , 0.05, p , 0.05,
and p , 0.005, respectively).
Table 5 compares and summarises the characteristics of
patients who succumbed and those who survived the
clostridium bacteraemia. Younger age and underlying gastro-
intestinal/hepatobiliary tract disease were associated with
mortality (p , 0.05 in all three comparisons).
Table 6 compares and summarises the characteristics of
those patients with clinically relevant clostridium bacterae-
mia and those with pseudobacteraemia. Underlying hepato-
biliary tract disease was associated with clinically relevant
bacteraemia (p , 0.01), whereas cerebrovascular accident
and immobilisation and/or bed sore were associated with
pseudobacteraemia (p , 0.05 and p , 0.005, respectively).
DISCUSSION
In our study, we defined the epidemiology, clinical spectrum,
and outcome of clostridium bacteraemia with the aid of 16S
rRNA gene sequencing. Most patients were old, and there
was a male predominance. Almost all patients had under-
lying diseases, with gastrointestinal and hepatobiliary tract
disease, malignancy, and hypertension being the most fre-
quent. As in previous reports,7–9 clostridium bacteraemia was
primarily community acquired (30 of 38) and often polymicro-
bial, with other endogenous bacteria concomitantly being
isolated (15 of 30). Among the 25 patients with documented
foci of infection, the hepatobiliary and gastrointestinal tracts
were the major portals of entry, because cholecystitis/cho-
langitis (eight patients) and intra-abdominal infections (five
patients) made up most of the diagnoses. Therefore, patients
with clinically relevant clostridium bacteraemia should be
investigated for the presence of underlying disease processes
in the hepatobiliary or gastrointestinal tracts. Although the
gastrointestinal tract was also the major site of entry in previous
studies,8 9 the reported incidences of both underlying hepato-
biliary tract disease and cholecystitis/cholangitis were much
lower than those reported in our series.We speculate that this is
attributable to our high prevalence of ductal stones, clonor-
chiasis, and recurrent pyogenic cholangitis.10 Similar to recent
studies (77%,7 21.7%,9 and 42%8), C perfringens was the most
common clostridium species associated with bacteraemia (30 of
38; 79%). However, the species responsible for the remainder of
the cases were diverse and varied among different studies.
Compared with C perfringens bacteraemia, non-perfringens
clostridium bacteraemia affected younger patients without
biliary tract disease and was more frequently hospital acquired.
‘‘The association between younger age and mortality is
probably the result of underlying diseases, because nine of
the 11 patients who died had either gastrointestinal or
hepatobiliary tract diseases’’
Clostridium bacteraemia, when it occurs in immuno-
compromised hosts, especially those with underlying gastro-
intestinal or hepatobiliary tract disease, should be managed
cautiously. Although various studies have failed to demon-
strate the effect of appropriate antimicrobial treatment on the
outcome of clostridium bacteraemia,7 8 the clinical relevance
of each episode should be carefully evaluated and appro-
priate treatment initiated in relevant cases. In patients with
underlying hepatobiliary tract disease, the isolation of
clostridium from blood cultures is often clinically relevant.
However, in those with an underlying cerebrovascular
accident or longterm immobilisation, the chance of encoun-
tering pseudobacteraemia is high, probably because of the
difficulties in venipuncture and the frequent use of femoral
veins. The mortality rate in clostridium bacteraemia was high
(29%). Younger age and underlying hepatobiliary and gastro-
intestinal tract disease were associated with increased risk of
death. The association between younger age and mortality is
Table 3 Summary of characteristics of patients with
clinically relevant clostridium bacteraemia
Characteristics Number of patients (%)
Year
1998 13 (34)
1999 10 (26)
2000 8 (22)
2001 7 (18)
Month
January 6 (16)
February 3 (8)
March 2 (5)
April 4 (11)
May 3 (8)
June 4 (11)
July 7 (18)
August 0 (0)
September 3 (8)
October 2 (5)
November 1 (3)
December 3 (8)
Mean age (SD, median, range;
in years)
62 (26.3, 74, 1 month to 95)
0–10 3 (8)
11–20 1 (3)
21–30 1 (3)
31–40 0 (0)
41–50 4 (11)
51–60 3 (8)
61–70 4 (11)
71–80 11 (29)
81–90 9 (24)
91–100 2 (5)
Sex (male:female) 23:15
Underlying disease*
Gastrointestinal tract disease 11 (29)
Hepatobiliary tract disease 11 (29)
Malignancy 11 (29)
Hypertension 11 (29)
Diabetes mellitus 7 (18)
Cerebrovascular accident 6 (16)
Immobilisation and/or bed sore 4 (11)
Chronic renal failure 3 (8)
None 4 (11)
Diagnosis
Primary bacteraemia 13 (34)
Cholecystitis/cholangitis 12 (32)
Other intra-abdominal infection 7 (18)
Infected gangrene of extremities 3 (8)
Infected bed sore 2 (5)
Pneumonia 1 (3)
Community/hospital acquired
Community 30 (79)
Hospital 8 (21)
Number of positive blood cultures
1 34 (89)
2 4 (11)
Monomicrobial/polymicrobial
bacteraemia
Monomicrobial 19 (50)
Polymicrobial 19 (50)
Mortality 11 (29)
*The percentages add up to more than 100% because some patients had
more than one underlying disease.
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Table 4 Comparison of characteristics of patients with Clostridium perfringens and those
with non-perfringens clostridium bacteraemia
Characteristics of blood culture isolate
Number of patients (%)
p Value
Clostridium perfringens
(n = 30)
Other clostridium species
(n = 8)
Sex NS
Male 18 (60) 5 (63)
Female 12 (40) 3 (38)
Mean age (SD) 70 (20.8) 41 (33.2) ,0.05
Underlying diseases*
Gastrointestinal tract disease 8 (27) 3 (38) NS
Hepatobiliary tract disease 9 (30) 2 (25) NS
Malignancy 7 (23) 4 (50) NS
Hypertension 10 (33) 1 (13) NS
Diabetes mellitus 6 (20) 1 (13) NS
Cerebrovascular accident 5 (17) 1 (13) NS
Immobilisation and/or bed sore 3 (10) 1 (13) NS
Chronic renal failure 3 (10) 0 (0) NS
Diagnosis
Primary bacteraemia 8 (27) 5 (63) NS
Cholecystitis/cholangitis 12 (40) 0 (0) ,0.05
Other intra-abdominal infection 5 (17) 2 (25) NS
Infected gangrene of extremities 3 (10) 0 (0) NS
Infected bed sore 1 (3) 1 (13) NS
Pneumonia 1 (3) 0 (0) NS
Community/hospital acquired
Community 27 (90) 3 (38)
Hospital 3 (10) 5 (63) ,0.005
Number of positive blood cultures
1 27 (90) 7 (88) NS
2 3 (10) 1 (13)
Mono/polymicrobial bacteraemia
Monomicrobial 15 (50) 4 (50) NS
Polymicrobial 15 (50) 4 (50) NS
Mortality 8 (26) 3 (38) NS
*The percentages add up to more than 100% because some patients had more than one underlying disease.
NS, not significant.
Table 5 Comparison of characteristics of patients who died of and those who survived
clostridium bacteraemia
Characteristics
Number of patients (%)
p ValueDied (n = 11) Survived (n = 27)
Sex
Male 9 (82) 14 (52) NS
Female 2 (18) 13 (48)
Mean age (SD) 49 (26.5) 70 (23.9) ,0.05
Underlying diseases*
Gastrointestinal tract disease 6 (55) 5 (19) ,0.05
Hepatobiliary tract disease 6 (55) 5 (19) ,0.05
Malignancy 4 (36) 7 (26) NS
Hypertension 2 (18) 9 (33) NS
Diabetes mellitus 1 (9) 6 (22) NS
Cerebrovascular accident 1 (9) 5 (19) NS
Immobilisation and/or bed sore 1 (9) 3 (11) NS
Chronic renal failure 2 (18) 1 (4) NS
Diagnosis
Primary bacteraemia 4 (36) 9 (33) NS
Cholecystitis/cholangitis 3 (27) 9 (33) NS
Other intra-abdominal infection 3 (27) 4 (15) NS
Infected gangrene of extremities 1 (9) 2 (7) NS
Infected bed sore 0 (0) 2 (7) NS
Pneumonia 0 (0) 1 (4) NS
Community/hospital acquired
Community 7 (64) 23 (85) NS
Hospital 4 (36) 4 (15)
Number of positive blood cultures
1 11 (100) 23 (85) NS
2 0 (0) 4 (15)
Mono/polymicrobial bacteraemia
Monomicrobial 3 (27) 16 (59) NS
Polymicrobial 8 (73) 11 (41) NS
*The percentages add up to more than 100% because some patients had more than one underlying disease.
NS, not significant.
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probably the result of underlying diseases, because nine of
the 11 patients who died had either gastrointestinal or
hepatobiliary tract diseases. This is in line with a previous
study from Taiwan in which younger age and underlying
liver cirrhosis were also shown to be associated with fatal
clostridium bacteraemia, although younger age was not an
independent risk factor in multivariate analysis.7 In a pre-
vious study on E coli bacteraemia, mortality was found to be
higher in patients with polymicrobial rather than mono-
microbial bacteraemia.11 There was also a trend for such an
association in our present study, but the difference was not
significant. Patients with risk factors for higher mortality
should be carefully treated with antibiotics and the source
promptly identified.
With the application of 16S rRNA gene sequencing, the
present report also described the first case of C disporicum
infection in humans, and two cases of clostridium bacter-
aemia in children presenting with intussusception. Clostri-
dium disporicum is a saccharolytic clostridium species first
isolated from the caecum of a rat.12 It was previously regarded
as a non-pathogenic clostridium species, because isolation of
this organism from humans has not been reported in the
literature. Our present patient (patient 34) with C disporicum
bacteraemia was admitted for uterine prolapse with ring
pessary inserted, and developed fever with neutrophilia after
admission. Although the source of the bacteraemia could not
be ascertained, the isolation of this bacterium suggests that
it is a potential human pathogen. As for the association
between intussusception in paediatric patients with clostri-
dium infections, to the best of our knowledge, the only case
documented in the English literature was a 19 month old girl
with ileocolic intussusception associated with C difficile
enterocolitis,13 (Medline search up to August 2004), whereas
intussusception in our two infants was associated with
C perfringens (patient 7) and C paraputrificum (patient 35).
Table 6 Comparison of characteristics of patients with clinically relevant clostridium
bacteraemia and those with clostridium pseudobacteraemia
Characteristics
Number of patients (%)
p Value
Clinically relevant
bacteraemia
(n = 38)
Pseudobacteraemia
(n = 30)
Sex
Male 23 (61) 13 (43) NS
Female 15 (39) 17 (57)
Mean age (SD) 64 (26.3) 70 (21.6) NS
Underlying disease*
Gastrointestinal tract disease 11 (29) 7 (23) NS
Hepatobiliary tract disease 11 (29) 1 (3) ,0.01
Malignancy 11 (29) 6 (20) NS
Hypertension 11 (29) 10 (33) NS
Diabetes mellitus 7 (18) 6 (20) NS
Cerebrovascular accident 6 (16) 13 (43) ,0.05
Immobilisation and/or bed sore 4 (11) 16 (53) ,0.005
Chronic renal failure 3 (8) 0 (0) NS
Blood culture isolate
C barati 0 (0) 1 (3) NS
C difficile 1 (3) 0 (0) NS
C disporicum 1 (3) 0 (0) NS
C indolis 0 (0) 1 (3) NS
C innocuum 0 (0) 1 (3) NS
C orbiscindens 0 (0) 1 (3) NS
C paraputrificum 1 (3) 3 (10) NS
C perfringens 30 (79) 21 (70) NS
C ramosum 3 (8) 0 (0) NS
C septicum 1 (3) 0 (0) NS
C sporosphaeroides 0 (0) 1 (3) NS
C tertium 1 (3) 1 (3) NS
Community/hospital acquired
Community 30 (79) 21 (70) NS
Hospital 8 (21) 9 (30)
Number of positive blood cultures
1 34 (89) 30 (100) NS
2 4 (11) 0 (0)
Mono/polymicrobial bacteraemia
Monomicrobial 19 (50) 16 (53) NS
Polymicrobial 19 (50) 14 (47) NS
*The percentages add up to more than 100% because some patients had more than one underlying disease.
NS, not significant.
Take home messages
N 16S rRNA gene analysis was useful for investigating
clostridium bacteraemia
N Clostridium perfringens accounted for 79% of all
clinically relevant bacteraemia, with the remainder
caused by a diversity of species
N The attributable mortality rate of clinically relevant
clostridium bacteraemia was 29%
N Younger age and underlying gastrointestinal/hepato-
biliary tract disease were associated with mortality and
patients with clinically relevant clostridium bacteraemia
should be investigated for the presence of underlying
disease processes in the gastrointestinal or hepatobili-
ary tracts
N 16S rRNA gene analysis will continue to be useful in
further understanding the pathogenicity of various
clostridium species
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Patient 7, who had polymicrobial C perfringens bacteraemia
after successful hydrostatic reduction, developed sudden
cardiac arrest and died on the day of admission, with the
same blood culture isolates recovered in postmortem tissues
of the terminal ileum and mesenteric lymph nodes. Patient
35, who had monomicrobial C paraputrificum bacteraemia,
presented with peritonitis and septic shock as a result of
small bowel ischaemia. He was cured after small bowel
resection and appropriate antibiotic treatment. In both
cases, there was probably bacterial translocation through
the inflamed intestinal mucosa, and the serious outcome
suggests that clostridium bacteraemia in patients with
intussusception may be a poor prognostic indicator.
The identification and classification of clostridium are
difficult because the genus is one of the most heterogeneous
bacterial genera and comprises more than 150 species. With
the availability of molecular techniques, most clostridium
species have been subjected to 16S rRNA gene sequence
analysis, and phylogenetic clusters have been defined and
many revisions made in their classification.14–18 The applica-
tion of these techniques to identify clinically important
clostridium isolates will better define the epidemiology,
clinical relevance, and pathogenic potential of various species
in the genus. Previous reports on clostridium bacteraemia
have relied on phenotypic identification of the blood culture
isolates, some of which may have been misidentified, and
rarely encountered species may have been missed. Large
numbers were reported as clostridium species that could
not be identified further (35%8 and 13%9). Given the diversity
of the genus, it is unlikely that commercially available
identification kits will include all clostridium species in their
databases. As PCR and sequencing techniques are becoming
more readily available in clinical laboratories, 16S rRNA gene
analysis is probably the most practical approach to identify
members of the genus clostridium to the species level.
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